Pioglitazone in Acute Ischemic Stroke Trial

INTERVENTION: Patients will be randomly selected to receive pioglitazone Patients will also be randomly selected to receive treatment with conventional therapy CONDITION: Ischemic stroke PRIMARY OUTCOME: NIH stroke scale score at 3 months SECONDARY OUTCOME: Recurrence of stroke and Cardiovascular event (cerebral hemorrhage, subarachnoid hemorrhage, myocardial infarction, angina pectoris, and ASO) within 3 months after starting treatment INCLUSION CRITERIA: 1.Admission within 7 days after the onset of ischemic stroke 2.Diabetes mellitus 3.cerebral thrombosis 4.NIHSS score 4‐15